Русский
Urolithiasis in HIV-positive patients: prevalence and risk factors
DOI: https://dx.doi.org/10.18565/urology.2023.4.136-140
I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, F.A. Yusupov
1) I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan; 2) Kyrgyz Russian Slavic University, Bishkek, Kyrgyzstan; 3) Research Institute of Molecular Biology and Medicine, Bishkek, Kyrgyzstan; 3) Scientific and Research Institute of Molecular Biology and Medicine, Bishkek, Kyrgyzstan; 4) FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia; 5) Osh State University, Osh, Kyrgyzstan
Today, the total number of people living with the human immunodeficiency virus (HIV) is 43.8 million. From the moment of infection to the terminal stage of the disease, the risk of stone formation progressively increases. A prevalence and role of individual risk factors for urolithiasis in patients with HIV are reviewed in the article. It is shown that in HIV-positive individuals, urolithiasis takes a leading position among renal diseases, with a prevalence ranging from 8 to 27%. The main risk factors for urolithiasis in HIV are: dietary factors, age, comorbid pathologies, use of protease inhibitors, changes in the ionic composition of urine, etc.
Keywords: prevalence of HIV infection, ionic composition of urine, healthcare, stone, kidneys, antiretroviral therapy, human immunodeficiency virus
About the Autors
Corresponding author: I.T. Murkamilov – Ph.D., MD, associate professor at the Department of Faculty Therapy of I.K. Akhunbaev Kyrgyz State Medical Academy, председатель правления Общества специалистов по хронической болезни почек of Kyrgyzstan, associate professor at the Department of Internal Disease No2 of GOU VPO KRSU named after B.N. Yeltsin, Bishkek, Kyrgyzstan; e-mail: murkamilov.i@mail.ru
Similar Articles
